Ondine Biomedical (LON:OBI) was awarded the TAYYABA HASAN IMPACT AWARD at the 18th World Congress of International Photodynamic Association (IPA) in Finland for demonstrating “exceptional perseverance and clinical...
Search results for - ondine
Ondine Biomedical names Simon Sinclair as CMO
Ondine Biomedical (LON:OBI) appointed Simon Sinclair, M.D., Ph.D., as chief medical officer, as the company prepares to start a U.S. Phase 3 trial of its nasal photodisinfection technology. Dr. Sinclair has more than 20...
Ondine presents effective photodisinfection treatment research against MRSA
Ondine Biomedical (LON:OBI) presented new research at the Infection Prevention Society Conference in Bournemouth, UK showing that its Steriwave photodisinfection technology is highly effective against clinical MRSA...
Ondine treats first patients in Phase 2 nasal photodisinfection trial
Ondine Biomedical (LON:OBI) treated the first patients in its nasal photodisinfection exploratory Phase 2 trial to evaluate how effectively the treatment eradicates pathogens – Staphylococcus aureus – in the nose, and...
Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board
Ondine Biomedical (LSE:OBI), appointed Prof. Trevor Jones, CBE FMedSci, to lead a new advisory board on the use of its pioneering photodisinfection-based technology to prevent and treat COVID-19. Ondine’s non-antibiotic...
Ondine Biomedical names Cameron Lawrence as COO, CFO
Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.
